ADC Digest – August 2020 ADC Digest – August 2020 Immunomedics announced FDA approval of Samsung Biologics as antibody manufacturer of Trodelvy 17 Aug 2020 Trodelvy: (Sacituzumab govitecan-hziy, DNA topoisomerase I inhibitor; Immunomedics) Immunomedics announced that the FDA has approved […]
ADC Digest – August 2020 ADC Digest – August 2020 Mersana Therapeutics received FDA fast track designation (FTD) for XMT-1536 for the treatment of patients with platinum-resistant ovarian cancer 11 Aug 2020 XMT-1536 (NaPi2b antibody; Mersana Therapeutics/Recepta Biopharma) FDA has […]
ADC Digest – August 2020 ADC Digest – August 2020 FDA approved GSK’s BLENREP (belantamab mafodotin-blmf) for the treatment of patients with relapsed or refractory multiple myeloma 06 Aug 2020 BLENREP (belantamab mafodotin-blmf, Tubulin polymerisation inhibitors; GSK) Approved as monotherapy […]
